Trade

with

Alexza Pharmaceuticals Inc
(NASDAQ: ALXA)
AdChoices
2.18
-0.03
-1.36%
After Hours :
-
-
-

Open

2.20

Previous Close

2.21

Volume (Avg)

61.19k (148.38k)

Day's Range

2.16-2.32

52Wk Range

1.99-5.93

Market Cap.

38.39M

Dividend Rate ( Yield )

-

Beta

1.27

Shares Outstanding

17.37M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Drug Manufacturers – Specific & Generic
Highlights
Analyst Recommendation: Hold
    • Revenue

    • 47.84M

    • Net Income

    • -39.62M

    • Market Cap.

    • 38.39M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -488.44

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.27

    • Forward P/E

    • -1.43

    • Price/Sales

    • 5.36

    • Price/Book Value

    • -1.06

    • Price/Cash flow

    • -0.84

      • EBITDA

      • -34.79M

      • Return on Capital %

      • -52.60

      • Return on Equity %

      • -

      • Return on Assets %

      • -52.60

      • Book Value/Share

      • -2.09

      • Shares Outstanding

      • 17.37M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Hold
        • 1 Year Price Target

        • 5.50

        • Credit Rating

        • -

        • Analysts

        • 1

        • EPS Estimate

        • -1.56

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -96.60

          • 7.67

          • Net Income

            YTD/YTD (last year)

          • -

          • -26.33

          • Net Income

            Q/Q (last year)

          • -

          • 197.54

          • Sales (Revenue)

            5-Year Annual Average

          • 150.40

          • -5.42

          • Net Income

            5-Year Annual Average

          • -

          • 3.16

          • Dividends

            5-Year Annual Average

          • -

          • -0.13

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -137.78

            • 64.72

            • Pre-Tax Margin

            • -488.44

            • 13.77

            • Net Profit Margin

            • -488.44

            • 10.84

            • Average Gross Margin

              5-Year Annual Average

            • 95.30

            • 67.80

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 15.58

            • Average Net Profit Margin

              5-Year Annual Average

            • -515.80

            • 343.47B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.33

              • Current Ratio

              • 5.31

              • 1.52

              • Quick Ratio

              • 4.60

              • 0.87

              • Interest Coverage

              • -7.91

              • 6.77

              • Leverage Ratio

              • -

              • 1.91

              • Book Value/Share

              • -2.09

              • 16.21

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -1.10

                • 63.69

                • P/E Ratio 5-Year High

                • -19.47

                • 237.47

                • P/E Ratio 5-Year Low

                • -0.99

                • 19.71

                • Price/Sales Ratio

                • 5.36

                • 3.57

                • Price/Book Value

                • -1.06

                • 3.35

                • Price/Cash Flow Ratio

                • -0.84

                • 21.41

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -

                    (-)

                  • 7.86

                    (9.58)

                  • Return on Assets %

                    (5-Year Average)

                  • -52.60

                    (-76.70)

                  • 4.14

                    (5.54)

                  • Return on Capital %

                    (5-Year Average)

                  • -

                    (-)

                  • 5.59

                    (7.66)

                  • Income/Employee

                  • -

                  • 27.79k

                  • Inventory Turnover

                  • 6.45

                  • 1.80

                  • Asset Turnover

                  • 0.11

                  • 0.38

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  1.77M
                  Operating Margin
                  3.70
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -0.84
                  Ownership

                  Institutional Ownership

                  51.72%

                  Top 10 Institutions

                  41.69%

                  Mutual Fund Ownership

                  15.76%

                  Float

                  98.55%

                  5% / Insider Ownership

                  4.30%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Swedbank Robur Medica

                  •  

                    852,000

                  • 0.00

                  • 5.02

                  • Carnegie Global Healthcare

                  •  

                    593,580

                  • 0.00

                  • 3.53

                  • Vanguard Total Stock Mkt Idx

                  •  

                    425,033

                  • 0.00

                  • 2.45

                  • AST Federated Aggressive Growth

                  •  

                    141,912

                  • -59.43

                  • 0.82

                  • Carnegie Biotechnology

                  •  

                    122,000

                  • 0.00

                  • 0.72

                  • Vanguard Extended Market Index Fund

                  •  

                    114,088

                  • 11.26

                  • 0.66

                  • Top Alpha Overseas Equity

                  •  

                    93,191

                  • -54.57

                  • 0.54

                  • Vanguard Instl Total Stock Market Index

                  •  

                    81,627

                  • 0.00

                  • 0.47

                  • iShares Micro-Cap

                  •  

                    63,618

                  • 1.28

                  • 0.33

                  • Bridgeway Ultra Small Company Market

                  •  

                    50,000

                  • 0.00

                  • 0.29

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • LANSDOWNE PARTNERS AUSTRIA GMBH

                  •  

                    1,426,235

                  • +5.24%

                  • 8.23

                  • Swedbank Robur Fonder AB

                  •  

                    852,000

                  • 0.00%

                  • 5.02

                  • Morgan Stanley & Co Inc

                  •  

                    841,247

                  • +12.04%

                  • 4.86

                  • Credit Suisse First Boston (CSFB)

                  •  

                    790,355

                  • -0.04%

                  • 4.56

                  • Credit Suisse Asset Management, LLC

                  •  

                    780,133

                  • -6.19%

                  • 4.51

                  • Carnegie Asset Management Fondsmæglersel

                  •  

                    715,580

                  • 0.00%

                  • 4.25

                  • Goldman, Sachs & Co.

                  •  

                    486,629

                  • +6.32%

                  • 2.81

                  • Vanguard Group, Inc.

                  •  

                    406,824

                  • +1.49%

                  • 2.35

                  • VHCP Management, LLC

                  •  

                    247,812

                  • 0.00%

                  • 1.43

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Drug Manufacturers – Specific & Generic

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Alexza Pharmaceuticals, Inc. was incorporated in the state of Delaware on December 19, 2000 as FaxMed, Inc. In June 2001, it changed the name to Alexza Corporation and in December 2001 it became Alexza Molecular Delivery Corporation....more In July 2005, it changed the name to Alexza Pharmaceuticals, Inc. It is a pharmaceutical company, engaged in the research, development and commercialization of novel proprietary products for the acute treatment of central nervous system conditions. ADASUVE is its only approved product & there is one product candidate in active development, AZ-002 (Staccato alprazolam), which is being developed for the treatment of acute repetitive seizures, sometimes called cluster seizures or ARS. ADASUVE, or Staccato loxapine, and its product candidates are based on its proprietary te...morechnology, the Staccato system. The Staccato system vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for rapid systemic drug delivery. Because of the particle size of the aerosol, the drug is quickly absorbed through the deep lung into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous, or IV, administration but with greater ease, patient comfort and convenience. The pharmaceutical and biotechnology industries are intensely competitive. Many pharmaceutical companies, biotechnology companies, public and private universities, government agencies and research organizations are actively engaged in research and development of products targeting the same markets as ADASUVE and its other product candidates. The names “Alexza Pharmaceuticals,” “Alexza,” “Staccato” and “ADASUVE” are trademarks of the Company. It helds 195 issued and allowed U.S. and international patents. The testing, manufacturing, labeling, advertising, promotion, distribution, export and marketing of the Company’s product candidates are subject to extensive regulation by governmental authorities in the United States and other countries.lessless

                  Key People

                  Thomas B. King

                  CEO/President/Director

                  Mr. Mark K. Oki

                  CFO/Chief Accounting Officer/Secretary/Senior VP, Divisional

                  Mr. Robert A. Lippe

                  COO/Executive VP, Divisional

                  Dr. James V. Cassella,PhD

                  Chief Scientific Officer/Executive VP, Divisional

                  Dr. J. Leighton Read,M.D.

                  Director

                  • Alexza Pharmaceuticals Inc

                  • 2091 Stierlin Court

                  • Mountain View, CA 94043

                  • USA.Map

                  • Phone: +1 650 944-7000

                  • Fax: +1 650 944-7999

                  • alexza.com

                  Incorporated

                  2000

                  Employees

                  90

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: